C-reactive protein and lipids may respond differently to statins.
Black
Donald M
DM
Global Strategic Regulatory Development, Merck and Company, 126 Lincoln Avenue, Rahway NJ, 07065-0900, USA. donald_black@merck.com
D002097:C-Reactive Protein / Q000032:analysis* / Q000187:drug effects; D008078:Cholesterol, LDL / Q000097:blood* / Q000187:drug effects; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D006949:Hyperlipidemias / Q000097:blood* / Q000188:drug therapy; D019821:Simvastatin / Q000494:pharmacology* / Q000627:therapeutic use
D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D002097:C-Reactive Protein; D019821:Simvastatin